-
Photocure: New Data on Cysview® to be presented at the upcoming AUA 2019 Annual Meeting
Oslo, Norway, April 8, 2019: Photocure ASA (PHO:OSE) announced today that Photocure will be exhibiting Blue Light Cystoscopy (BLC™) with Cysview in Booth 2214, during the American Urological Association Meeting (AUA 2019) in Chicago May 3rd-6th.
08 Apr 2019 -
Patients want Blue Light Cystoscopy
A large survey posted by the Bladder Cancer Advocacy Network (BCAN) and published in UroToday revealed a growing preference for Cysview®
28 Mar 2019 -
Patients want Blue Light Cystoscopy
A large survey posted by the Bladder Cancer Advocacy Network (BCAN) and published in UroToday revealed a growing preference for Cysview®.
28 Mar 2019 -
Hexvix® / Cysview® with Flexible Cystoscopy improves Bladder Cancer detection. Data presented at the EAU congress in Barcelona.
(The press release is updated with the following sentences: This means that in this survey more than 50% of the patients said they were willing to pay $100 or more out of their own pocket to get the blue light procedure. This is not linked to the price or reimbursement of the Cysview® drug. From January 2019 Cysview® for use in the office with flexible scopes is reimbursed.)
19 Mar 2019 -
Photocure ASA: Hexvix® /Cysview® with Flexible Cystoscopy improves Bladder Cancer detection. Data presented at the EAU congress in Barcelona.
Oslo, Norway March 19, 2019, Photocure ASA (PHO:OSE), is pleased to announce that Blue Light Cystoscopy (BLC™) with Hexvix® was presented at the European Association of Urology (EAU) congress held in Barcelona, Spain, March 15th -18th. The EAU annual meeting is one of the largest international meetings in the urology calendar, showcasing the latest and most relevant knowledge in urology with more than 14,000 urologists and exhibitors from over 110 countries.
19 Mar 2019 -
Photocure ASA: Q&A session with Dan Schneider on Facebook
Oslo, Norway, 8 March 2019: Photocure will on Wednesday 13 March 2019 13:00 (CET) stream a Q&A live session with Photocure's President and CEO Dan Schneider via the Facebook group "Photocure Investors" and https://www.facebook.com/groups/aksjekunnskap/ and https://www.facebook.com/groups/Aksjeforum/
It will be open for questions before and during the session. Pål Falck, health analytics at Arctic, will moderate the session.
11 Mar 2019 -
Photocure ASA: Results for the fourth quarter of 2018
Oslo, Norway, 27 February 2019: Photocure ASA (OSE:PHO), today reported a revenue growth of 76% in local currency for the U.S. market in the fourth quarter of 2018, contributing to Hexvix/Cysview revenues of NOK 46.3 million (Q4 2017: NOK 39.4) and a recurring EBITDA of NOK -4.1 million (NOK -13.1 million). The company maintains its 2020 forecasted revenue range of USD 20-25 million in the U.S., up from USD 7.8 million in 2018, and sees significant continued revenue growth and profit opportunities in the U.S. market beyond 2020.
27 Feb 2019 -
Photocure ASA - share capital increase registered
Reference is made to the announcement on 14 February 2019 in respect of a capital increase of 17,379 new shares following the execution of the employee long-term incentive program for restricted shares in the company.
22 Feb 2019 -
Photocure ASA: Invitation to fourth quarter and full year 2018 results presentation and webcast
Photocure will present its fourth quarter report on Wednesday 27 February 2019 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET).
20 Feb 2019 -
Bladder Cancer Survivor Story
NewsChannel 5, the CBS-affiliate in Nashville, TN, USA has featured the Bladder Cancer Survivor's Story of Mary Beth Ballard Murray, who is coming up on her 5 years survivorship.
14 Dec 2018 -
Blue Light Cystoscopy featured in Everyday Urology from UroToday
An article by Ashish Kamat, highlighting Blue Light Cystoscopy with Cysview and current evidence on recurrence and progression.
10 Dec 2018 -
Photocure to present at Nordic-American Life Science Conference in New York
Oslo, Norway, 29 November 2018: Photocure ASA (OSE: PHO) is pleased to announce that Photocure will be presenting at the Nordic-American Life Science Conference in New York today. The presentation will be held by Daniel Schneider, President and CEO of Photocure ASA.
29 Nov 2018 -
Photocure ASA: Mandatory notification of trade13 Nov 2018